this post was submitted on 10 May 2024
114 points (100.0% liked)
Technology
37707 readers
264 users here now
A nice place to discuss rumors, happenings, innovations, and challenges in the technology sphere. We also welcome discussions on the intersections of technology and society. If it’s technological news or discussion of technology, it probably belongs here.
Remember the overriding ethos on Beehaw: Be(e) Nice. Each user you encounter here is a person, and should be treated with kindness (even if they’re wrong, or use a Linux distro you don’t like). Personal attacks will not be tolerated.
Subcommunities on Beehaw:
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
🤖 I'm a bot that provides automatic summaries for articles:
Click here to see the summary
Neuralink, the brain-computer interface startup run by controversial billionaire Elon Musk, did not immediately respond to a request for comment from Ars.The goal is for the threads to be placed near neurons of interest so that signals detected by the electrodes can be recorded and decoded into intended actions, such as moving a cursor on a computer screen.
On January 28, the company announced that it has surgically implanted its brain-computer interface into its first clinical trial participant, 29-year-old Noland Arbaugh, who developed quadriplegia after a 2016 diving accident.
It remains unclear why the threads moved from their placement, but one hypothesis that sources told the Journal is that there was air trapped inside Arbaugh's skull after the surgery, a condition called pneumocephalus.
However, the company reported that the retraction of the threads lowered his bits-per-second (BPS) rate, which is used to measure how quickly and accurately a patient with an implant can control a computer cursor.
The Journal reported that the company has told the Food and Drug Administration—which regulates clinical trials and granted approval for Neuralink to test its device in humans—that it believes it has fixes for the problem.
Saved 68% of original text.